🔎 Trials Near Me

Beranda › Mielofibrosis › Tennessee › Nashville

Uji klinis Mielofibrosis di Nashville, TN

9 studi untuk Mielofibrosis mencari peserta di lokasi sekitar Nashville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Menerima pesertaFase 1/2
  • Tri-Star Centennial Medical Center, Nashville
  • Vanderbilt University, Nashville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Menerima pesertaFase 3
  • Vanderbilt-Ingram Cancer Center (VICC)-Nashville, Nashville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07623161

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Menerima pesertaFase 1
  • Tennessee Oncology, PLLC - Investigational Drug Services, Nashville
  • Tristar BMT, Nashville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07469891

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Menerima pesertaFase 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06661915

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Menerima pesertaFase 1
  • Tristar Bmt/Tcto, Nashville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07441694

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

Menerima pesertaFase 2
  • GSK Investigational Site, Nashville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT06517875

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Menerima pesertaFase 1
  • Vanderbilt University Medical Center, Nashville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Nashville
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Menerima pesertaFase 3
  • Tennessee Oncology, Nashville
  • Vanderbilt University Medical Center, Nashville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2025 · NCT06479135

Uji klinis Mielofibrosis di kota lain

Studi lain di Nashville

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.